Page last updated: 2024-12-08

9-(4'-aminophenyl)-9h-pyrido(3,4-b)indole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID154224
SCHEMBL ID15263336
MeSH IDM0379952

Synonyms (22)

Synonym
benzenamine, 4-(9h-pyrido(3,4-b)indol-9-yl)-
ccris 9009
4-(9h-pyrido(3,4-b)indol-9-yl)benzenamine
aminophenylnorharman
apnh cpd
9-(4'-aminophenyl)-9h-pyrido(3,4-b)indole
4-pyrido[3,4-b]indol-9-ylaniline
FT-0662021
nmc04j95oa ,
219959-86-1
unii-nmc04j95oa
9-(4'-aminophenyl)-9h-pyrido[3,4-b]indole
SCHEMBL15263336
4-(beta-carboline-9-yl)aniline
4-(9h-pyrido(3,4-b)indole-9-yl)aniline
4-(9h-.beta.-carbolin-9-yl)aniline
j1.034.926e ,
DTXSID70176423
AKOS030255864
J-014402
Q27284949
4-(9h-pyrido[3,4-b]indol-9-yl)aniline

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" No toxic changes were observed in Leydig cells under these conditions and serum follicle-stimulating hormone and luteinizing hormone concentrations were also unchanged from control values."( Testicular toxicity in F344 rats by aminophenylnorharman, formed from norharman and aniline.
Hisada, S; Ishihara, J; Kawamori, T; Mitsumori, K; Sugimura, T; Totsuka, Y; Wakabayashi, K, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.47 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]